Dr. Kutny is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 7th Ave S
Birmingham, AL 35233Phone+1 205-934-3795Fax+1 205-975-8991
Education & Training
- University of WashingtonFellowship, Pediatric Hematology/Oncology, 2008 - 2011
- Vanderbilt University Medical CenterResidency, Pediatrics, 2005 - 2008
- Vanderbilt University School of MedicineClass of 2005
Certifications & Licensure
- AL State Medical License 2011 - 2024
- WA State Medical License 2008 - 2013
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer Start of enrollment: 2017 Nov 29
- Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
- A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Start of enrollment: 2019 Jul 03
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsOutcomes of Referrals in Pediatric Patients With Peripheral Lymphadenopathy.Kathryn A Six, Inmaculada B Aban, Gabriel M Daniels, Julie Wolfson, Elizabeth A Beierle
Journal of Pediatric Hematology/oncology. 2024-08-01 - 2 citationsBosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.Erica Brivio, Edoardo Pennesi, Marieke E Willemse, Alwin D R Huitema, Yilin Jiang
Journal of Clinical Oncology. 2024-03-01 - 15 citationsCharacteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.Sara Zarnegar-Lumley, Todd A Alonzo, Robert B Gerbing, Megan Othus, Zhuoxin Sun
Blood Advances. 2023-10-10
Press Mentions
- Chemotherapy-Free Regimen Benefits Children with Acute Promyelocytic LeukemiaFebruary 2nd, 2022
- A Gentler Standard for Acute Promyelocytic Leukemia in KidsNovember 11th, 2021
- Arsenic Trioxide Consolidation Effective in Pediatric Acute Promyelocytic LeukemiaAugust 21st, 2017
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: